Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5925-5935
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5925
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5925
Table 2 Parameters with potential influence on the sensitivity of Endoscopic ultrasound-fine needle aspiration n (%)
Parameter | P value | ||
Tumor echogenicity | Homogenous (solid) | Heterogeneous (necrotic) | |
EUS-FNA-sensitivity | 11/20 (55) | 18/32 (56) | 1.0 |
Tumor size | < 30 mm | ≥ 30 mm | |
EUS-FNA-sensitivity | 10/18 (56) | 19/34 (56) | 1.0 |
ROSE | ROSE | non-ROSE | |
EUS-FNA-sensitivity | 21/34 (62) | 8/18 (44) | 0.26 |
FNA-needle | 22 gauge | 25 gauge | |
EUS-FNA-sensitivity | 20/37 (54) | 9/15 (60) | 0.77 |
FNA-passes | < 3 passes | ≥ 3 passes | |
EUS-FNA-sensitivity | 9/17 (53) | 20/35 (57) | 1.0 |
Sampling order1 | EUS-FNA first | EUS-FNB first | |
EUS-FNA-sensitivity | 12/19 (61) | 10/19 (53) | 0.63 |
- Citation: Hedenström P, Nilsson B, Demir A, Andersson C, Enlund F, Nilsson O, Sadik R. Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies. World J Gastroenterol 2017; 23(32): 5925-5935
- URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5925.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5925